BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38284270)

  • 1. Validation of a novel algorithm with a high specificity in ruling out MDS.
    Schulz F; Nachtkamp K; Oster HS; Mittelman M; Gattermann N; Schweier S; Barthuber C; Germing U
    Int J Lab Hematol; 2024 Jun; 46(3):510-514. PubMed ID: 38284270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS.
    Oster HS; Crouch S; Smith A; Yu G; Abu Shrkihe B; Baruch S; Kolomansky A; Ben-Ezra J; Naor S; Fenaux P; Symeonidis A; Stauder R; Cermak J; Sanz G; Hellström-Lindberg E; Malcovati L; Langemeijer S; Germing U; Holm MS; Madry K; Guerci-Bresler A; Culligan D; Sanhes L; Mills J; Kotsianidis I; van Marrewijk C; Bowen D; de Witte T; Mittelman M
    Blood Adv; 2021 Aug; 5(16):3066-3075. PubMed ID: 34387647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is bone marrow examination always necessary to establish the diagnosis of myelodysplastic syndromes? A proposed non-invasive diagnostic model.
    Oster HS; Carmi G; Kolomansky A; Joffe E; Kaye I; Kirgner I; Greenbaum U; Comaneshter D; Mittelman M
    Leuk Lymphoma; 2018 Sep; 59(9):2227-2232. PubMed ID: 29295649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoplastic myelodysplastic syndrome.
    Nand S; Godwin JE
    Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratory.
    Zhu J; Lemaire P; Mathis S; Ronez E; Clauser S; Jondeau K; Fenaux P; Adès L; Bardet V
    BMC Cancer; 2022 Sep; 22(1):972. PubMed ID: 36088307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GDF11 level in patients with myelodysplastic syndrome and its clinical significance].
    Han Y; Wang H; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Song J; Guan J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Shao Z
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(8):620-4. PubMed ID: 26932855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in the classification of CMML--dysplastic versus proliferative type.
    Germing U; Gattermann N; Minning H; Heyll A; Aul C
    Leuk Res; 1998 Oct; 22(10):871-8. PubMed ID: 9766745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.
    Dinmohamed AG; van Norden Y; Visser O; Posthuma EF; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Leuk Res; 2015 Feb; 39(2):177-82. PubMed ID: 25533930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study.
    Raskovalova T; Jacob MC; Bulabois CE; Mariette C; Scheffen L; Park S; Labarère J
    Ann Hematol; 2021 May; 100(5):1149-1158. PubMed ID: 33569703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
    Merchant SH; Gonchoroff NJ; Hutchison RE
    Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of dysplasia in peripheral blood: Proposal of an algorithm to detect myelodysplastic syndromes and chronic myelomonocytic leukemias on a high-speed technical platform using the Sysmex XN™ analyser.
    Bouriche L; Fuster L; Laurent H; Soler C; Benhabib S
    Int J Lab Hematol; 2024 Apr; 46(2):286-293. PubMed ID: 38083991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.
    Rashidi HH; Xu X; Wang HY; Shafi NQ; Rameshkumar K; Messer K; Smith BR; Rose MG
    Int J Clin Exp Pathol; 2012; 5(3):224-30. PubMed ID: 22558477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts.
    Kasprzak A; Assadi C; Nachtkamp K; Rudelius M; Haas R; Giagounidis A; Götze K; Gattermann N; Germing U
    Ann Hematol; 2023 Jan; 102(1):99-106. PubMed ID: 36409328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
    Singh ZN; Post GR; Kiwan E; Maddox AM
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.